Treatment Benefit and Treatment Harm Rate to Characterize Heterogeneity in Treatment Effect

Biometrics

Volumn 69, Issue 3, 2013, Pages 724-731

  Shen, Changyu ^a   Jeong, Jaesik ^a   Li, Xiaochun ^a   Chen, Peng Sheng ^b   Buxton, Alfred ^c,d  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Causal inference; Heterogeneity in treatment effect; Potential outcomes; Sub group analysis

Indexed keywords

DEFIBRILLATORS; IMPLANTABLE CARDIOVERTER DEFIBRILLATORS; PATIENT TREATMENT;

CAUSAL INFERENCES; GROUP ANALYSIS; HETEROGENEITY IN TREATMENT EFFECT; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; IMPLANTABLE CARDIOVERTERS-DEFIBRILLATORS; POTENTIAL OUTCOMES; RANDOMIZED TRIAL; SUB-GROUP ANALYSE; SUB-GROUPS; TREATMENT EFFECTS;

SENSITIVITY ANALYSIS;

BIOMETRY; DISEASE TREATMENT; HETEROGENEITY; MORTALITY; NUMERICAL MODEL; PUBLIC HEALTH;

ARTICLE; BIOMETRY; CAUSAL INFERENCE; COMPUTER SIMULATION; HEART ARRHYTHMIA; HETEROGENEITY IN TREATMENT EFFECT; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; METHODOLOGY; MORTALITY; POTENTIAL OUTCOMES; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS; SUB-GROUP ANALYSIS; TREATMENT OUTCOME;

CAUSAL INFERENCE; HETEROGENEITY IN TREATMENT EFFECT; POTENTIAL OUTCOMES; SUB-GROUP ANALYSIS;

ARRHYTHMIAS, CARDIAC; BIOMETRY; COMPUTER SIMULATION; DEFIBRILLATORS, IMPLANTABLE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84901240608     PISSN: 0006341X     EISSN: 15410420     Source Type: Journal    
DOI: 10.1111/biom.12038     Document Type: Article

References (20)

1. Albert, J. M., Gadbury, G. L., and Mascha, E. J. (2005). Assessing treatment effect heterogeneity in clinical trials with blocked binary outcomes. Biometrical Journal 47, 662-673.
2. Andersen, P. K. and Gill, R. D. (1982). Cox's regression model for counting processes: A large sample study. The Annals of Statistics 10, 1100-1120.
3. Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., McNulty, S. E., Clapp-Channing, N., Davidson-Ray, L. D., Fraulo, E. S., Fishbein, D. P., Luceri, R. M., and Ip, J. H. (2005). Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. New England Journal of Medicine 352, 225-237.
4. Davidoff, F. (2009). Heterogeneity is not always noise: Lessons from improvement. The Journal of the American Medical Association 302, 2580-2586.
5. Foster, J. C., Taylor, J. M. G., and Ruberg, S. J. (2011). Subgroup identification from randomized clinical trial data. Statistics in Medicine 30, 2867-2880.
6. Gadbury, G. L. and Iyer, H. K. (2000). Unit-treatment interaction and its practical consequences. Biometrics 56, 882-885.
7. Gadbury, G. L., Iyer, H. K., and Albert, J. M. (2004). Individual treatment effects in randomized trials with binary outcomes. Journal of Statistical Planning and Inference 121, 163-174.
8. Gadbury, G. L., Iyer, H. K., and Allison, D. B. (2001). Evaluating subject-treatment interaction when comparing two treatments. Journal of Biopharmaceutical Statistics 11, 313-333.
9. Goldenberg, I., Vyas, A. K., Hall, W. J., Moss, A. J., Wang, H., He, H., Zareba, W., McNitt, S., and Andrews, M. L. (2008). Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. Journal of the American College of Cardiology 51, 288-296.
10. Holland, P. W. (1986). Staitstics and causal inference. Journal of the American Statistical Association 81, 945-960.
11. Jasjeet, S. S. (2011). Multivariate and propensity score matching software with automated balance optimization. Journal of Statistical Software 42, 1-52.
12. Kent, D. M. and Hayward, R. A. (2007). Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. The Journal of the American Medical Association 298, 1209-1212.
13. Lipkovich, I., Dmitrienko, A., Denne, J., and Enas, G. (2011). Subgroup identification based on differential effect search-a recursive partitioning method for establishing response to treatment in patient subpopulations. Statistics in Medicine 30, 2601-2621.
14. Lo, S. and Singh, K. (1985). The product-limit estimator and the bootstrap: Some asymptotic representations. Probability Theory and Related Fields 71, 455-465.
15. Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., and Andrews, M. L. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New England Journal of Medicine 346, 877-883.
16. Rubin, D. B. (1976). Inference and missing data. Biometrika 63, 581-592.
17. Rubin, D. B. (2007). The design versus the analysis of observational studies for causal effects: Parallels with the design of randomized trials. Statistics in Medicine 26, 20-36.
18. Tung, R., Zimetbaum, P., and Josephson, M. E. (2008). A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. Journal of the American College of Cardiology 52, 1111-1121.
19. van der Vaart, A. W. (2000). Asymptotic Statistics. Cambridge: Cambridge University Press.
20. Wang, R., Lagakos, S. W., Ware, J. H., Hunter, D. J., and Drazen, J. M. (2007). Statistics in medicine-Reporting of subgroup analyses in clinical trials. New England Journal of Medicine 357, 2189-2194.